Justification for the evaluation of the effects of an allergy to bufexamac in the context of the evaluation of reduction in earning capacity [Begründung für die beurteilung der auswirkung einer allergie gegenüber bufexamac im rahmen der MdE-bewertung]

DC ElementWertSprache
dc.contributor.authorWeisshaar, E.
dc.contributor.authorDiepgen, T.L.
dc.contributor.authorBecker, D.
dc.contributor.authorDickel, H.
dc.contributor.authorGeier, J.
dc.contributor.authorJohn, S.M.
dc.contributor.authorLessmann, H.
dc.contributor.authorMahler, V.
dc.contributor.authorRogosky, E.
dc.contributor.authorSkudlik, C.
dc.contributor.authorWagner, E.
dc.date.accessioned2021-12-23T16:29:52Z-
dc.date.available2021-12-23T16:29:52Z-
dc.date.issued2008
dc.identifier.issn1438776X
dc.identifier.urihttps://osnascholar.ub.uni-osnabrueck.de/handle/unios/16398-
dc.description.abstractThe following evidence-based recommendations help to evaluate the effects of an allergy to bufexamac with regard to the excluded job possibilities as necessary for the evaluation of the reduction in earning capacity in occupational skin diseases according to BK No. 5101, German regulation for occupational diseases. Bufexamac is hardly used as an occupational substance. Sensitizations are frequent but mainly not occupationally acquired. In persons working in the medical sector, an occupational causation is theoretically possible. It can be assumed that the occupational skin contact with bufexamac can be avoided, either by using another substance, by organizational measures at the work place or by wearing appropriate gloves. The prevalence of an allergy to bufexamac is considered mild. © 2008 Dustri-Verlag Dr. Karl Feistle.
dc.language.isode
dc.publisherDustri-Verlag Dr. Karl Feistle
dc.relation.ispartofDermatologie in Beruf und Umwelt
dc.subjectbufexamac, 2438-72-4
dc.subjectAllergic contact dermatitis
dc.subjectBufexamac
dc.subjectbufexamac, compensation
dc.subjectcontact sensitization
dc.subjectdelayed hypersensitivity
dc.subjectDelayed type allergy
dc.subjectevaluation
dc.subjectgovernment regulation
dc.subjecthuman
dc.subjectjob finding
dc.subjectmedical assessment
dc.subjectmedical literature
dc.subjectmedical profession
dc.subjectOccupational dermatology
dc.subjectoccupational skin disease
dc.subjectPatch test
dc.subjectprevalence
dc.subjectprotective clothing
dc.subjectshort survey
dc.subjectskin protection
dc.titleJustification for the evaluation of the effects of an allergy to bufexamac in the context of the evaluation of reduction in earning capacity [Begründung für die beurteilung der auswirkung einer allergie gegenüber bufexamac im rahmen der MdE-bewertung]
dc.typejournal article
dc.identifier.doi10.5414/dbp56031
dc.identifier.scopus2-s2.0-42549090585
dc.identifier.urlhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-42549090585&doi=10.5414%2fdbp56031&partnerID=40&md5=65e9c6bb9caa220ae7577d5a6f1cdabb
dc.description.volume56
dc.description.issue1
dc.description.startpage31
dc.description.endpage33
dcterms.isPartOf.abbreviationDermatol. Beruf Umwelt
crisitem.author.deptUniversität Osnabrück-
crisitem.author.deptUniversität Osnabrück-
crisitem.author.orcid0000-0001-5406-9458-
crisitem.author.netidJoSw269-
Zur Kurzanzeige

Seitenaufrufe

4
Letzte Woche
0
Letzter Monat
0
geprüft am 09.05.2024

Google ScholarTM

Prüfen

Altmetric